ETFs positioned on Merck KGaA

Name Weight AuM 1st Jan change Investor Rating
2.34% 2 M€ +13.56% -
2.01% 0 M€ 0.00% -
2.01% 0 M€ 0.00% -
1.80% 962 M€ -.--% -
1.20% 79 M€ -.--%
0.97% 14 M€ +8.62% -
0.77% 17 M€ +3.59%
0.75% 18 M€ +7.68%
0.58% 2 M€ +7.45%
0.47% 178 M€ +8.40%
0.35% 6 M€ -.--% -
0.33% 257 M€ +9.15%
0.30% 4 M€ -.--% -
0.29% 6 M€ -.--%
0.23% 3,859 M€ +18.82%
0.23% 469 M€ -1.75%
0.13% 10 M€ -3.35% -
0.11% 276 M€ +11.40% -
0.11% 34 M€ +0.49% -
0.09% 268 M€ +12.22% -
0.09% 204 M€ +11.05% -
0.09% 471 M€ +13.61%
0.09% 36 M€ +4.91% -
0.06% 205 M€ -.--%
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Employees
62,345
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
155.00EUR
Average target price
180.81EUR
Spread / Average Target
+16.65%
Consensus